Problems with Current Pharmacologic Treatment of Parkinson's Disease

This publication has 49 references indexed in Scilit:

• Treatment of Early Parkinson's Disease: Are Complicated Strategies Justified?
  Mayo Clinic Proceedings, 1996
• Wearing‐off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanisms
  Annals of Neurology, 1994
• Continuous lisuride effects on central dopaminergic mechanisms in Parkinson's disease
  Annals of Neurology, 1992
• Nigrostriatal Damage is Required for Induction of Dyskinesias by l-DOPA in Squirrel Monkeys
  Clinical Neuropharmacology, 1990
• ‘Subcorttcal dementia’: The neuropsychological evidence
  Neuroscience, 1988
• Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm study
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
• HOW COMMON IS DEMENTIA IN PARKINSON'S DISEASE?
  The Lancet, 1984
• Chapter 9
  Clinical Neuropharmacology, 1978
• Six Years of High-Level Levodopa Therapy in Severely Akinetic Parkinsonian Patients
  Archives of Neurology, 1976
• Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations
  Journal of the Neurological Sciences, 1973